Apolipoprotein E polymorphisms and mortality in Italian Type 2 diabetic patients

European Journal of Clinical Investigation

Volumn 33, Issue 4, 2003, Pages 296-300

  Boemi, Massimo ^a   Sirolla, C ^a   Testa, R ^a   Gregorio, F ^b   Brandoni, G ^a   Fumelli, P ^a   James, R W ^c  

^a INRCA   (Italy)

^b Ospedale di Fabriano   (Italy)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiovascular; Genetic; Lipoproteins; Risk factor

Indexed keywords

APOLIPOPROTEIN E; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEATH CERTIFICATE; DISEASE DURATION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ITALY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL;

APOLIPOPROTEINS E; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0037392362     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01141.x     Document Type: Article

References (25)

1. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
2. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-49.
3. Menzel HJ, Kladetzky RG, Assman G. Apolipoprotein E polymorphism and coronary heart disease. Arteriosclerosis 1983;3:310-5.
4. Lehtinen S, Lehtimaki T, Sisto T, Salenius JP, Nikkila M, Jokela H et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 1995;114:83-91.
5. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-5.
6. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9.
7. Gerdes LU, Gerdes C, Kervinen K, Savolainen M, Klausen IC, Hansen PS et al. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation 2000;101:1366-71.
8. Lee JH, Tang MX, Schupf N, Stern Y, Jacobs DM, Tycko B et al. Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet 2001;103:121-7.
9. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol 2002;22:146-55.
10. Laakso M, Kesäniemi A, Kervinen K, Jauhiainen M, Pyörälä K. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. Br Med J 1991;303:1159-62.
11. Kataoka S, Robbins DC, Cowan LD, Go O, Yeh JL, Devereux RB et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol 1996;16:918-25.
12. Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D, James RW. Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care 1995;18:504-8.
13. Vauhkonen I, Niskanen L, Ryynanen M, Voutilainen R, Partanen J, Toyry J et al. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet Med 1997;14:748-56.
14. James RW, Ruiz J, Blanché H, Pometta D, Passa P, Froguel P. Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clinica Chimica Acta 1994;225:77-82.
15. Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M et al. Apolipoprotein E polymorphism and hyperlipidemia in type II diabetes. Diabetes 1986;35:1374-82.
16. Marcais C, Bernard S, Merlin M, Ulhmann M, Mestre B, Rochet-Mingret L et al. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency. Diabetologia 2000;43:1346-52.
17. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81(4A):7B-12B.
18. Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 1998;(Suppl.):M8-14.
19. Ukkola A, Kervinen K, Salmela P, von Dickhoff K, Laakso M, Kesäniemi YA. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1993;101:9-16.
20. Rubin J, Berglund L. Apolipoprotein E and diets: a case of gene-nutrient interaction? Curr Opin Lipidol 2002;13:25-32.
21. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb 1994;14:1617-24.
22. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol in older persons and women: review of an NHLBI workshop. Ann Epidemiol 1992;2:161-76.
23. Krumholz HM, Seeman TE, Merrill SS. Mendes de Leon CF, Vaccarino V, Silverman DI et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause of mortality in persons older than 70 years. JAMA 1994;272:1335-40.
24. Boemi M, James RW, Romagnoli F, Gerber P, Pometta D, Fumelli P. Gender differences in a Type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia 1993;36:229-33.
25. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14.